| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
3 companies
Kazam Joshua A is a Director at ALLO, with reported holdings spanning 3 companies. Recent filings cover 4 purchases and 0 sales. Those positions are worth an estimated $236K at current prices.
Kazam Joshua A's largest disclosed position is in CAPR as Director, worth about $134K. Net of sales, the recent Form 4 record there shows accumulation of 7,096 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 12, 2022 | ALLO Allogene Therapeutics, Inc. | Director | Buy | 15,000 | $12.60 | $189,000.00 | +6.2% | -31.0% | -43.2% | |
| Mar 5, 2019 | TH Target Hospitality Corp. | Director | Buy | 5,000 | $10.20 | $51,000.00 | +100.0% | - | - | |
| Mar 1, 2019 | TH Target Hospitality Corp. | Director | Buy | 5,000 | $10.13 | $50,650.00 | New | - | - | |
| Jan 21, 2015 | CAPR Capricor Therapeutics, Inc. | Director | Buy | 7,096 | $3.52 | $24,999.21 | +22.9% | - | - |